Sino Biopharmaceutical Ltd (SBMFF)
0.3112
-0.02
(-7.27%)
USD |
OTCM |
Jun 26, 16:00
Sino Biopharmaceutical Enterprise Value: 6.664B for June 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 26, 2024 | 6.664B |
| June 25, 2024 | 7.123B |
| June 24, 2024 | 7.466B |
| June 21, 2024 | 7.466B |
| June 20, 2024 | 7.466B |
| June 18, 2024 | 7.466B |
| June 17, 2024 | 7.466B |
| June 14, 2024 | 7.466B |
| June 13, 2024 | 7.466B |
| June 12, 2024 | 7.466B |
| June 11, 2024 | 7.769B |
| June 10, 2024 | 7.769B |
| June 07, 2024 | 7.769B |
| June 06, 2024 | 7.769B |
| June 05, 2024 | 7.769B |
| June 04, 2024 | 7.685B |
| June 03, 2024 | 7.685B |
| May 31, 2024 | 7.685B |
| May 30, 2024 | 6.735B |
| May 29, 2024 | 6.735B |
| May 28, 2024 | 6.735B |
| May 24, 2024 | 6.735B |
| May 23, 2024 | 6.735B |
| May 22, 2024 | 6.735B |
| May 21, 2024 | 6.735B |
| Date | Value |
|---|---|
| May 20, 2024 | 6.735B |
| May 17, 2024 | 6.735B |
| May 16, 2024 | 6.735B |
| May 15, 2024 | 6.735B |
| May 14, 2024 | 6.735B |
| May 13, 2024 | 6.735B |
| May 10, 2024 | 6.735B |
| May 09, 2024 | 6.735B |
| May 08, 2024 | 6.735B |
| May 07, 2024 | 6.735B |
| May 06, 2024 | 6.735B |
| May 03, 2024 | 6.735B |
| May 02, 2024 | 6.735B |
| May 01, 2024 | 6.735B |
| April 30, 2024 | 6.735B |
| April 29, 2024 | 6.735B |
| April 26, 2024 | 6.735B |
| April 25, 2024 | 6.735B |
| April 24, 2024 | 6.735B |
| April 23, 2024 | 6.735B |
| April 22, 2024 | 6.735B |
| April 19, 2024 | 6.735B |
| April 18, 2024 | 7.384B |
| April 17, 2024 | 8.014B |
| April 16, 2024 | 8.014B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.289B
Minimum
Oct 02 2023
29.10B
Maximum
Jul 20 2020
14.41B
Average
14.56B
Median
Feb 02 2022
Enterprise Value Benchmarks
| Global Pharmatech Inc | -- |
| HUTCHMED (China) Ltd | 2.248B |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 48.41M |
| Prenetics Global Ltd | 12.41M |
Enterprise Value Related Metrics
| Earnings Yield | 5.70% |
| Operating Earnings Yield | 14.13% |
| Normalized Earnings Yield | 4.744 |